| Zacks Company Profile for Arch Therapeutics, Inc. (ARTHQ : OTC) |
|
|
| |
| • Company Description |
| Arch Therapeutics, Inc. is a medical device company. It develops products that make surgery and interventional care faster and safer by using an approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The Company's lead product candidate includes AC5 (TM), a biocompatible synthetic peptide, to achieve hemostasis in minimally invasive and open surgical procedures. Arch Therapeutics, Inc. is headquartered in Wellesley, Massachusetts.
Number of Employees: 8 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $ |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 402 shares |
| Shares Outstanding: 4.74 (millions) |
| Market Capitalization: $ (millions) |
| Beta: 13.63 |
| 52 Week High: $0.98 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
% |
% |
| 12 Week |
% |
% |
| Year To Date |
% |
% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Terrence W. Norchi - President; Chief Executive Officer and Chairman of
Michael S. Abrams - Chief Financial Officer
Punit Dhillon - Director
Laurence Hicks - Director
Dr. Guy L. Fish - Director
|
|
Peer Information
Arch Therapeutics, Inc. (ABMD)
Arch Therapeutics, Inc. (DMDS)
Arch Therapeutics, Inc. (CPWY.)
Arch Therapeutics, Inc. (EQUR)
Arch Therapeutics, Inc. (ECIA)
Arch Therapeutics, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 03939W208
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 06/01/24
Next Expected EPS Date: 08/18/25
|
|
Share - Related Items
Shares Outstanding: 4.74
Most Recent Split Date: 1.00 (0.01:1)
Beta: 13.63
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: % |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/18/25 |
|
|
|
| |
